Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Gross Profit (2016 - 2025)

Historic Gross Profit for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $9.5 million.

  • Standard Biotools' Gross Profit fell 2178.79% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.6 million, marking a year-over-year increase of 5086.85%. This contributed to the annual value of $84.3 million for FY2024, which is 6702.08% up from last year.
  • Standard Biotools' Gross Profit amounted to $9.5 million in Q3 2025, which was down 2178.79% from $10.6 million recorded in Q2 2025.
  • Standard Biotools' Gross Profit's 5-year high stood at $50.7 million during Q4 2024, with a 5-year trough of $4.4 million in Q2 2022.
  • Over the past 5 years, Standard Biotools' median Gross Profit value was $13.4 million (recorded in 2023), while the average stood at $16.0 million.
  • In the last 5 years, Standard Biotools' Gross Profit plummeted by 7579.29% in 2022 and then surged by 27984.58% in 2024.
  • Standard Biotools' Gross Profit (Quarter) stood at $22.7 million in 2021, then tumbled by 50.74% to $11.2 million in 2022, then grew by 19.61% to $13.4 million in 2023, then soared by 279.85% to $50.7 million in 2024, then plummeted by 81.31% to $9.5 million in 2025.
  • Its Gross Profit was $9.5 million in Q3 2025, compared to $10.6 million in Q2 2025 and $19.7 million in Q1 2025.